EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) fair value: what the stock is really worth

As of Sep 25, 2026: fair value of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi TRY 23.25, price TRY 22.94, upside +1.3%, quality 54 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Basic Materials · TR · ISIN TREKLKM00025

KK Thin data Sep 27, 2026

Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi

KLKIM · IS

NeutralThe stock looks roughly fairly valued with average quality.

·Fair value 23.25 TRY · Fairly valued (+1.3%)
!Quality 54/100
✓Healthy Growth (revenue 5y +82.6 %/yr)
!Thin margins · 9.2% net margin (TTM)
✓Low debt · generates free cash flow
✓2.8% dividend yield · Sustainable
✓Ranks above peers (10/11)
!Moderate moat 56/100
!Evidence only low, so the estimate is less certain
Watch Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

42.66 TRY 2.57 TRY Fair Value 23.25 TRY Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

60‑month range 2.57 TRY – 42.66 TRY · fair‑value band 17.37 TRY – 33.30 TRY · the 22.94 TRY price screens below the 23.25 TRY fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 27, 2026.

Follow Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi in your weekly email

Every Wednesday you see whether Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi operates in the construction chemicals sector in Turkey and internationally. It operates through the Construction Chemicals; and Concrete, Cement Chemicals, and Raw Materials segments.

Show more

Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi operates in the construction chemicals sector in Turkey and internationally. It operates through the Construction Chemicals; and Concrete, Cement Chemicals, and Raw Materials segments. Its product portfolio includes waterproofing products, such as cement -based, acrylic-based, bitumen-based, polyurethane-based, and membrane-based waterproofing products, as well as impregnated primers and waterproofing bands; tile adhesives, including cement, acrylic, and resin-based adhesives, as well as cement, epoxy, and resin-based grouts; and surface cleaning and maintenance products, sealants, and tile levelling systems. It also provides cement and epoxy-based repair mortars, cement and epoxy-based grout mortars, primers and additives, and cement-based smoothing screeds for technical applications; primers and coverings, industrial coverings, cement-based hardeners, surface hardeners, and curing materials for floor applications; decorative products, interior paints, exterior paints and plasters, surface preparation materials, and coloring systems for paints and decorative applications; and system components, adhesives and plasters, decorative coatings, and complementary accessories for thermal insulation applications. In addition, it offers bathroom, kitchen, pool, balcony and terrace, basement and foundation, floor, interior, and facade solutions; and assembly and sealing products. The company was incorporated in 1973 and is headquartered in Istanbul, Turkey. Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi operates as a subsidiary of H. Ibrahim Bodur Holding Anonim Sirketi.

Stock analysis

Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) currently trades at 22.94 TRY, while our model-based Fair Value estimate is 23.25 TRY, so the stock looks roughly fairly valued today (gap 1.3%).

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 106.40 TRY per share, and 22 of the 26 models we run sit above the 22.94 TRY price.

Bear case: the Dividend Discount group reads lowest at 5.56 TRY, and 4 of the 26 models stay below the price. Evidence for this calculation is low.

Scenario range: 17.37 TRY (bear) to 33.30 TRY (bull), the price of 22.94 TRY sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 54/100 (solid quality), in the Basic Materials sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi reported revenue of 10.7B TRY in FY2025 versus 810M TRY in FY2021, a compound +90.6%/yr. Reported net income was 1.1B TRY in FY2025, compounding +51.9%/yr from FY2021.

Key figures

Market cap 11.8B TRY (≈ $241M) · P/S ratio 1.12 · EPS (TTM) 0.0200 TRY · Dividend yield 2.8% · Net margin 10.6% · Return on equity 16.0% · Return on assets (EBIT) 21.2% · Operating margin 9.4%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

The share trades about 46% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −54% fair-value upside, at 1%, KLKIM screens cheaper than that median.

Fair Value models

Bear 17.37 TRY Fair Value 23.25 TRY Bull 33.30 TRY
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 49.37 TRY 66.95 TRY 118.24 TRY 76
Growth DCF 46.60 TRY 71.79 TRY 111.13 TRY 75
EPV 36.01 TRY 39.66 TRY 42.62 TRY 74
All 26 models by family
DCF Models
FCF DCF 49.37 TRY 66.95 TRY 118.24 TRY 76
Owner Earnings 34.86 TRY 63.06 TRY 112.27 TRY 71
5Y Revenue Exit 38.05 TRY 57.94 TRY 99.26 TRY 68
5Y EBITDA Exit 47.68 TRY 77.37 TRY 135.47 TRY 70
5Y P/E Exit 41.51 TRY 78.90 TRY 128.67 TRY 66
10Y Revenue Exit 41.36 TRY 74.37 TRY 92.70 TRY 65
10Y EBITDA Exit 48.18 TRY 92.04 TRY 166.11 TRY 63
10Y P/E Exit 44.32 TRY 80.71 TRY 137.82 TRY 60
Earnings-Based
Graham-Dodd 16.80 TRY 117.18 TRY 164.44 TRY 61
Lynch FV 60.54 TRY 86.48 TRY 112.43 TRY 59
PEG = 1.0 60.54 TRY 86.48 TRY 112.43 TRY 55
EPV 36.01 TRY 39.66 TRY 42.62 TRY 74
Dividend Discount
Gordon GGM 3.50 TRY 5.86 TRY 7.60 TRY 66
DDM Multi-Stage 3.50 TRY 5.56 TRY 6.30 TRY 65
Multiples
P/E Multiple 31.50 TRY 42.01 TRY 52.51 TRY 63
P/S Multiple 26.16 TRY 34.88 TRY 43.60 TRY 58
P/B Multiple 31.50 TRY 42.01 TRY 52.51 TRY 55
EV/EBIT 55.26 TRY 71.81 TRY 88.35 TRY 66
EV/EBITDA 46.68 TRY 60.37 TRY 74.05 TRY 67
EV/Revenue 30.03 TRY 40.50 TRY 50.96 TRY 54
Asset-Based
NCAV (Graham) 7.07 TRY 9.47 TRY 14.14 TRY 54
Growth DCF
Growth DCF 46.60 TRY 71.79 TRY 111.13 TRY 75
Rev-Margin DCF 41.19 TRY 65.48 TRY 116.51 TRY 68
Economic Profit
Residual Income 13.50 TRY 17.25 TRY 26.14 TRY 72
ROIC Compounder 42.14 TRY 54.69 TRY 68.85 TRY 70
Growth Earnings
Growth-Adj P/E 74.48 TRY 106.40 TRY 138.32 TRY 65

Open the full fair value analysis →

Notify me when KLKIM reaches fair value

Put KLKIM on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 54/100

Of which business quality 57 · Market factors (momentum, volatility) 29

Profitability 69
Margins and returns on capital today
Quality Growth 45
Are margins and returns improving?
Cashflow 60
Earnings quality: real cash, not paper profit
Fin. Strength 82
Balance sheet, leverage, solvency risk
Investment 23
Disciplined investing over empire-building
Low Volatility 77
Calm price path (market factor)
Momentum 13
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 40
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+9.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+70.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+82.6%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+63.2%
What shareholders gained per year (last 5 years), in TRY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TRY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+30.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+27.6%
Dividend (yield on the price)2.8%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.17% → 20%

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+3.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Turkey: IMF forecast 19.3% a year to 2030, 28.5% from 2016 to 2025) that is about −13.2% a year for the price.

Watch KLKIM, get fair value alerts →

Compare Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 706 stocks

Beats the industry median on 9/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 54 · Above median
Fair Value upside +1.3% · Above median
Profitability
Return on equity (TTM) 16.0% · Top 25%
Return on assets 13.5% · Top 25%
Net margin (TTM) 9.2% · Above median
Operating margin (TTM) 9.4% · Above median
Growth and dividend
Revenue growth −7.9% · Bottom 25%
Dividend yield (TTM) 2.8% · Above median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/S (TTM) 0.02× · Cheapest 25%
P/FCF 0.2× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)35 · sector 0
FUTURE (revenue growth)0 · sector 26
PAST (return on equity)64 · sector 23
HEALTH (low debt)100 · sector 95
DIVIDEND (yield)57 · sector 29

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Linde plc LIN $469.89 $441.72 −6%
The Sherwin-Williams Company SHW $329.10 $151.68 −54%
Ecolab Inc ECL $279.49 $96.56 −65%
Air Products and Chemicals, Inc APD $281.76 $121.30 −57%
Givaudan SA GIVN CHF 3,447 CHF 1,527 −56%
Wanhua Chemical Group 600309 ¥69.45 ¥68.03 −2%
DSM-Firmenich AG DSFIR CHF 92.30 CHF 29.70 −68%
Asian Paints Limited ASIANPAINT ₹2,444 ₹1,479 −39%
PPG Industries, Inc PPG $107.52 $76.98 −28%
EMS-CHEMIE HOLDING AG EMSN CHF 820.50 CHF 284.63 −65%

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi Fair Value". https://www.fairvalue-calculator.com/stock/KLKIM

Frequently asked questions

Is Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of 23.25 TRY versus a price of 22.94 TRY, about +1% upside (fairly valued).
What is the fair value of KLKIM?
Our model-based fair value for Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 23.25 TRY (as of Sep 27, 2026), built from audited fundamentals. The current price: 22.94 TRY.
What is the quality score of KLKIM?
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Our model-based price target is the fair value of 23.25 TRY (as of Sep 27, 2026) from 26 valuation models. Cautious scenario 17.37 TRY, optimistic scenario 33.30 TRY. It is a calculation from audited fundamentals, not an analyst target.
What is the Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi stock forecast for 2026?
Our models put fair value at 23.25 TRY, about +1% upside versus a price of 22.94 TRY (fairly valued). Cautious scenario 17.37 TRY, optimistic scenario 33.30 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi reported trailing-twelve-month revenue of about 10.5B TRY (latest available figure, as of Sep 27, 2026).
Does Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi pay a dividend?
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi currently shows a dividend yield of about 2.84% relative to its recent price (as of Sep 27, 2026).
What growth is priced into Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
For today's price to be fair in a discounted-cash-flow model, Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi would have to grow free cash flow by +3.6 % per year for five years (discount rate 17.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +82.7 % per year. As of Sep 27, 2026.
What discount rate (WACC) does the fair value of KLKIM use?
Our models discount Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi at 17.2 %: a base by market capitalisation (micro), country premium for Turkey. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi that is +3.6 % per year a year over ten years, using the same discount rate (17.2 %) and the same formula as our fair value.
How much growth has Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) delivered so far?
Over the past 5 years revenue at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi grew +82.7 % a year. The price currently implies +3.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) growing?
The median revenue growth in the sector is +3.7 % a year. That is the yardstick for the growth priced into Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (+3.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The free-cash-flow yield on the price is 10.76 %: that much free cash flow Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi produces per unit of market value. When it exceeds the discount rate of our models (17.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi it is 23.25 TRY per share (as of Sep 27, 2026), against a price of 22.94 TRY. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi stock overvalued or undervalued in 2026?
As of Sep 27, 2026, KLKIM trades below its calculated fair value: price 22.94 TRY, fair value 23.25 TRY, a gap of about +1% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of KLKIM?
No. The price is what the market pays today (22.94 TRY); the fair value is what the company's own numbers justify (23.25 TRY). For Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi the two are 0.3050 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi worth?
The market values Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi at about 11.8B TRY (market capitalisation, as of Sep 27, 2026). Per share that is 22.94 TRY; our models calculate a fair value of 23.25 TRY per share.
What do the bullish and bearish scenarios say about KLKIM?
Our models span a range for Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi: cautious scenario 17.37 TRY, base 23.25 TRY, optimistic 33.30 TRY per share (as of Sep 27, 2026, price 22.94 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Balance-sheet figures for Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (as of Sep 27, 2026): return on equity 16.0%. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is KLKIM from its 52-week high?
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi trades at 22.94 TRY, about 46% below its 52-week high of 42.66 TRY and at the low of 22.94 TRY (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of 23.25 TRY is for.
Which stocks are comparable to Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi stock attractive at the current price?
The data as of Sep 27, 2026: price 22.94 TRY, calculated fair value 23.25 TRY (+1%), Quality Score 54/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of KLKIM calculated?
We run Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 23.25 TRY, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.9 % above its aggregate fair value. Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi currently trades 1 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The closing price on Sep 25, 2026 was 22.94 TRY. Our model-based fair value is 23.25 TRY, about +1% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (17.37 TRY to 33.30 TRY) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi

How large is the market capitalisation of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The market capitalisation of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 11.8B TRY (≈ $241M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The price-to-sales ratio of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 1.12 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Earnings per share at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi are 0.0200 TRY. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The dividend yield of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 2.8%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The net margin of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 10.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The return on equity (ROE) of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 16.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
On an EBIT basis the return on assets of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 21.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The operating margin of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 9.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Revenue at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is growing −7.9% versus a year earlier (3y avg +70.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Earnings per share at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi are growing −90.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) carry?
The net debt of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 49.2M TRY (fiscal year 2018, ≈ 0.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi in the live analysis

One click puts Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.